ALC

#398
Alcon Inc. Ordinary Shares
66.2 8 USD
+0.49%
Сектор: Здравоохранение
Базовая: USD
Валюта прибыли: USD
Дневной диапазон
66.19
66.70
Годовой диапазон
61.84
92.55
Дневное изменение
+0.49%
Месячное изменение
-9.71%
6-месячное изменение
-16.39%
Годовое изменение
-24.08%
Предыдущее закрытие
65.9 6
Open
66.4 2
Low
66.1 9
High
66.7 0
Volume
2 248
Открыть полный график Full chart

Financials

Обзор Отчетность Статистика Дивиденды
Квартал Год
  • Market Capitalization 32.31 B
  • Employee 26 K
  • Founded N/A
  • CEO David J. Endicott
  • Website www.alcon.com
  • Headquarter Switzerland
  • FIGI UNKNOWN
  • Industry Медицинские инструменты и расходники
Общий доход
Чистая прибыль
Общий долг
Свободный денежный поток
Денежные средства и эквиваленты

Alcon Inc. Ordinary Shares

Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people. Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies.

Новости